Today

Agents

Chat

Arena

Discover

More

App

Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock - LIMN News | Rallies

Liminatus Pharma Announces Reverse Stock Split Of Its Common Stock

LIMN•2026-08-18

Reverse stock split announced

Aug. 18 (Reuters) - Liminatus Pharma Inc. LIMN.O:

Liminatus Pharma, Inc. announces reverse stock split of its common stock.
Liminatus Pharma announces a 1-for-50 reverse stock split.
The reverse stock split is effective August 20, 2026; split-adjusted trading begins August 21, 2026.

Related News

OpenAI Says Paused Frontier Model Inference In Research Clusters After Hugging Face Incident

MSFT•2026-08-18

Agenus extends $24.75 million loan maturity to Nov. 2029 in Ocean 1181 amendment

AGEN•2026-08-18

Oak Valley Bancorp director H. Randolph Holder Jr acquires 115 common shares for $3,881.25

OVLY•2026-08-18

Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $265,370

CYTK•2026-08-18

United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $4.79 million

UTHR•2026-08-18